NOV-205

· Cellectar Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NOV-205, covering 2007-12-21 to 2022-07-25. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy [Phase 2]